-+ 0.00%
-+ 0.00%
-+ 0.00%

Keros Therapeutics Files Prospectus For Offering $350M Mixed Shelf; May Offer $100M Common Shares Under Sales Agreement With Leering Partners

Benzinga·09/10/2026 20:06:06
Listen to the news

SEC.